Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case

Paul Komenda1, Nadia Zalunardo2, Shelley Burnett2

  • 1Department of Medicine, Division of Nephrology, St. Paul's Hospital, Division of Nephrology, University of British Columbia, 1081 Burrard Street, Providence Wing RM 6010A, Vancouver, BC, V6Z 1Y8, Canada. paulkomenda@gmail.com.

Insights

A conservative outpatient protocol effectively prevented contrast-induced nephropathy in high-risk chronic kidney disease patients undergoing cardiac angiography. This approach warrants further investigation in randomized trials to confirm safety and efficacy.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Radiocontrast-induced nephropathy (CIN) prevention strategies for high-risk patients undergoing cardiac angiography remain debated.
  • Patients with chronic kidney disease (CKD) and low estimated glomerular filtration rates (eGFRs) face increased risk of kidney function decline or dialysis post-contrast.
  • This risk can lead to withholding or delaying life-saving procedures like angiography.

Purpose of the Study:

  • To evaluate a standardized outpatient protocol for preventing CIN in patients with CKD undergoing angiography.
  • To assess the safety and efficacy of this protocol in a case series.

Main Methods:

  • A case series of 31 CKD patients undergoing cardiac or peripheral angiography, or angioplasty/stenting for renal artery stenosis (RAS).
  • Patients followed an outpatient protocol: withholding diuretics, ACE inhibitors (ACEs)/angiotensin receptor blockers (ARBs) pre- and post-procedure, with calcium channel blockers administered peri-procedurally.
  • Bloodwork was conducted at 2-3 and 7-10 days post-procedure.

Main Results:

  • Mean baseline creatinine was 214 micromol/l, with a mean eGFR of 34 ml/min (range 12-59 ml/min).
  • All patients had baseline eGFR < 60 ml/min, with stages ranging from 3 to 5 CKD.
  • No patient required urgent hemodialysis post-angiography, and no change in kidney function progression rate was observed during 26 months of follow-up.

Conclusions:

  • The described conservative, outpatient protocol appears effective for high-risk CKD patients undergoing cardiac angiography.
  • This protocol merits further investigation through randomized controlled trials to validate its findings.
Abstract

Related Concept Videos

Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...